August 19, 2025

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: A Glimpse into Its 21.62% Potential Upside

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a leading player in the healthcare sector under the Medical Instruments & Supplies industry, is presenting a potential investment opportunity that might capture the attention..

National HealthCare Corporation (NHC) Stock Analysis: A Stable Dividend Play with Robust Revenue Growth

National HealthCare Corporation (NYSE: NHC) stands as a notable player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $1.67 billion, the company..

LivaNova PLC (LIVN) Stock Analysis: Healthcare Innovator’s 21% Upside Potential Captures Investor Attention

LivaNova PLC (NASDAQ: LIVN), a prominent player in the healthcare sector, has become a focal point for investors seeking opportunities in medical technology. The company, headquartered in London, operates in..

Liquidia Corporation (LQDA) Stock Analysis: A Biotech Growth Story with 32% Potential Upside

Liquidia Corporation (NASDAQ: LQDA) is capturing investor attention with its significant 32.28% potential upside, as suggested by analyst ratings. As a key player in the biotechnology sector, the company is..

Kiniksa Pharmaceuticals, Ltd. (KNSA) Stock Analysis: 37.9% Potential Upside Drives Strong Investor Interest

Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) is capturing investor attention with a compelling growth narrative and a substantial 37.9% potential upside based on analyst ratings. Specializing in developing therapies for unmet..

BGM Group Ltd. (BGM) Stock Analysis: Navigating Challenges in the Healthcare Sector

BGM Group Ltd. (BGM), entrenched in the specialized niche of Drug Manufacturers – Specialty & Generic within the healthcare sector, is a company that has captured attention for its unique..

Twist Bioscience Corporation (TWST) Stock Analysis: A Healthcare Innovator with 42.76% Potential Upside

Twist Bioscience Corporation (NASDAQ: TWST) stands out in the healthcare sector, particularly within diagnostics and research. With its innovative approach to synthetic DNA-based products, the company offers a unique value..

Vericel Corporation (VCEL) Stock Analysis: Exploring a 48% Upside Potential with Strong Buy Ratings

Vericel Corporation (NASDAQ: VCEL), a prominent player in the biotechnology sector, has captured the attention of investors with its innovative approach to cellular therapies and specialty biologic products. Based in..

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Exploring a Potential 10% Upside in the Healthcare Sector

Guardian Pharmacy Services, Inc. (NASDAQ: GRDN) emerges as a compelling opportunity for investors seeking exposure in the healthcare sector, particularly in the niche of pharmacy services for long-term care facilities..

Zai Lab Limited (ZLAB)

⚠️ No article content returned.

..

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: Unveiling a 90% Upside Potential

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) has garnered significant attention within the biotechnology sector, primarily due to its promising drug pipeline and strategic alliances with industry giants such as GlaxoSmithKline, Pfizer..

Perrigo Company plc (PRGO) Stock Analysis: Navigating a 48.72% Potential Upside with Robust Dividends

Perrigo Company plc (NYSE: PRGO), a staple in the healthcare sector, is making waves in the investor community with a noteworthy 48.72% potential upside, according to analyst ratings. As a..

Kymera Therapeutics, Inc. (KYMR) Stock Analysis: A Compelling 38.40% Potential Upside with Strong Buy Ratings

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a pioneering biopharmaceutical company, has captured the attention of investors with its innovative approach to drug development and a notable potential upside of 38.40%. Headquartered..

Protagonist Therapeutics, Inc. (PTGX) Stock Report: Unveiling a 24% Potential Upside in the Biotech Sector

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) stands out in the competitive biotechnology sector, capturing the attention of investors with its promising pipeline and a significant potential upside. With a market capitalization..

Crinetics Pharmaceuticals, Inc. (CRNX) Stock Analysis: A 133% Potential Upside in the Biotech Sector

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX), a clinical-stage biotechnology company based in San Diego, California, is making waves in the healthcare sector. With a market capitalization of $2.8 billion, the company..

CONMED Corporation (CNMD) Stock Analysis: Evaluating a 14.25% Upside Potential in the Medical Device Sector

Investors with a keen interest in the healthcare sector, particularly in the medical devices industry, may find CONMED Corporation (NASDAQ: CNMD) a noteworthy consideration. With a market capitalization of $1.65..

PROCEPT BioRobotics (PRCT) Stock Analysis: A Promising 62.67% Upside in the Healthcare Sector

For investors eyeing the healthcare sector, PROCEPT BioRobotics Corporation (NASDAQ: PRCT) represents a compelling opportunity with significant growth potential. The company’s focus on innovative medical devices in urology positions it..

Ardent Health, Inc. (ARDT) Stock Analysis: 52.72% Potential Upside Ignites Investor Interest

Ardent Health, Inc. (ARDT) presents a compelling opportunity for investors seeking exposure in the healthcare sector, particularly within the medical care facilities industry. Based in Brentwood, Tennessee, and operating as..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: A 23.61% Upside Opportunity for Investors

Alignment Healthcare, Inc. (NASDAQ: ALHC) stands out in the healthcare sector with its impressive potential upside of 23.61%, making it a compelling consideration for investors eyeing growth opportunities. This Orange,..

Merus N.V. (MRUS) Stock Analysis: Exploring a 36.97% Potential Upside in Biotech

Merus N.V. (MRUS), a Netherlands-based biotechnology company, is making waves in the healthcare sector with its innovative approach to immuno-oncology. With a market capitalization of $4.99 billion, Merus is positioning..

Search

Funds

August 19, 2025

Search

Funds

August 19, 2025

FTSE 100

Funds